Fig. 2From: Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patientsPlasma chitotriosidase, CCL18, glucosylsphingosine (GlcSph) and glucosylceramide (GlcCer) in patients previously treated with ERT. a–d: individual levels. Dotted lines represent reference values (see legend Fig 1). Time between start ERT and SRT is variable between patients (range 7–13 year). * blue star indicates patient no 19Back to article page